Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Virginia for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Virginia only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Virginia (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

David Salib (NPI 1053367946)

Field	Value
Entity Type	Individual
Organization	David Salib
Address	241 Corporate Blvd
City	Norfolk
State	VA
ZIP	23502
Taxonomy	Ophthalmology Physician
NPI Enumerated	May 25, 2006

Payer Source	Total Paid
Medicare	$2.5M
Medicaid	$0

Key Findings

Practice is highly concentrated on intravitreal biologic therapy: J0178 (aflibercept) represents $1.9M and 78.7% of this provider's Medicare revenue with 2.8K claims at $692 avg paid/claim. This single code dominates the revenue profile and suggests the practice operates a high-volume injection service focused on retinal disease management.

Top-3 concentration is extremely high: the precomputed top 3 Medicare codes account for 91.9% of total Medicare revenue, indicating heavy dependence on a very small set of services for $2.5M in Medicare revenue. That level of concentration can make overall revenue sensitive to changes in drug pricing, reimbursement policy, or clinical demand for those specific services.

Clinical and operational footprint appears to be an office-based retina/injection model: along with J0178, the provider bills 67028 (intravitreal injection) — 1.6K claims, $94 avg paid/claim, $147.4K revenue (6.0% of Medicare revenue) — and generates substantial E/M volume through 99214 (1.9K claims, $93 avg paid/claim, $180.7K revenue, 7.3%). The mix of high-volume drug administration, procedural injection codes, and frequent mid-level E/M visits is consistent with a steady follow-up regimen typical of anti-VEGF treatment protocols.

Competitive standing for key services is above average to extreme: J0178 ranks #218 of 3204 providers nationally (93th percentile; notably above typical national volume), and 99214 ranks #1475 of 479517 providers nationally (100th percentile; extreme outlier), indicating unusually high office visit and drug-administration activity relative to peers. By contrast, 67028 ranks #727 of 4255 providers nationally (83th percentile; typical, unremarkable volume), so the provider is particularly prominent for drug-related billing and E/Ms rather than being uniformly dominant across all retinal procedures.

Diagnostic imaging is also a relative strength: 92134 (retinal OCT) appears at 2.8K claims, $29 avg paid/claim, $82K revenue (3.3% of Medicare revenue) and ranks #475 of 26868 providers nationally (98th percentile; extreme outlier). High OCT volume alongside intravitreal injections reinforces a care model centered on active retinal disease management and monitoring.

This provider is effectively single-payer from a state program perspective: total Medicare revenue is $2.5M while there is no Medicaid billing on file. Analysts should treat the practice as Medicare-dependent for public-payer revenue exposure and not expect Medicaid claims data to explain its service mix.

Tenure in Medicare billing is long-standing: the NPI was enumerated on 2006-05-25 (~20 years ago), indicating an established practice presence to support the sustained high volumes reported for aflibercept, E/M visits, and retinal imaging. Longevity increases the plausibility of an established operational workflow for frequent injections and follow-up visits.

Other billed items show typical or limited activity: J3590 (unclassified biologics) generated $48.8K (18 claims, $2709 avg paid/claim) and is described as typical, unremarkable volume (ranks #593 of 631 providers nationally, 4th percentile). This suggests the provider does not rely meaningfully on a broad set of miscellaneous biologic codes beyond the primary aflibercept activity.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

13 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J0178	Injection, aflibercept, 1 mg	2,810	$690	$1.9M
99214	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the…	1,940	$90	$180.7K
67028	The provider injects a medication into the vitreous chamber of the eye as an isolated procedure or a separate procedure unrelated to any other procedure being performed on the eye.	1,570	$90	$147.4K
92134	The provider performs computerized diagnostic imaging of the retina in the posterior segment (back part) of the eye, interprets the data, and provides a report. The service may be on one or both eyes.	2,830	$30	$82K
J3590	Unclassified biologics	20	$2,710	$48.8K
92014	An ophthalmologist sees an established patient for a comprehensive level eye examination. Generally, a patient is considered to be "established" if the same physician, or any physician in the group…	230	$70	$16.6K
J9035	Injection, bevacizumab, 10 mg	290	$50	$15.9K
99213	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the…	260	$50	$13.8K
99204	The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the provider…	110	$110	$11.9K
92235	The provider uses a special dye, fluorescein that causes the blood vessels in the one or both eyes to stand out in photographic images taken with the use of multiframe timing, or serial images, taken…	40	$100	$3.6K

Showing 1–10 of 13

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 13 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. Virginia Distribution

David Salib — 2 of 13 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — Virginia

Full comparison — all codes billed, vs. state median

13 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J0178	16	80	1,400	$690	$1.1M
J3590	12	20	40	$2,290	$126K
67028	28	90	1,000	$90	$107.1K
92014	370	870	170	$80	$32.8K
99214	33	12,890	140	$80	$21K
J9035	18	60	170	$50	$19.9K
99213	2,366	12,440	90	$60	$10K
92134	25	680	70	$30	$9.7K
92235	27	50	40	$110	$7.3K
99204	697	6,850	40	$110	$5.9K

Showing 1–10 of 13

Related Providers

Other providers that share a Tax Identification Number (TIN) with David Salib, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Harbinder Brar	CA	Maternal & Fetal Medicine Physician	$0	$31.3M
Ravindra Gautam	CA	Internal Medicine Physician	$13M	$0
Virginia Eye Consultants Inc	VA	Ophthalmology Physician	$0	$8.3M
John O'keefe	VA	Ophthalmology Physician	$4.8M	$0
Juan Astruc	VA	Ophthalmology Physician	$4.7M	$0
Rohit Adyanthaya	VA	Ophthalmology Physician	$4.1M	$0
Bryan Schwent	VA	Ophthalmology Physician	$3.7M	$0
Thomas Jenkins	VA	Ophthalmology Physician	$2.8M	$0
Rizwan Nurani	CA	Radiation Oncology Physician	$2.4M	$0
Evan Berger	VA	Retina Specialist (Ophthalmology) Physician	$2M	$0

Nearby Providers

Other providers in the same ZIP code as David Salib, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Sentara Hospitals	VA	General Acute Care Hospital	$0	$79.7M
Tremont Road Dental Super, P.C.	VA	General Practice Dentistry	$0	$63.5M
Sentara Medical Group	VA	Family Medicine Physician	$0	$48.7M
Emergency Physicians Of Tidewater	VA	Emergency Medicine Physician	$0	$47.9M
Community Alternative Inc	VA	Community/Behavioral Health Agency	$0	$44.3M
Life's Journey	VA	Adult Mental Health Clinic/Center	$0	$24.4M
Keys To Success Family & Developmental Services	VA	Community/Behavioral Health Agency	$0	$16.1M
Advantage Home Care, LLC	VA	Home Health Agency	$0	$15.7M
National Counseling Group, Inc	VA	Mental Health Counselor	$0	$14.5M
Childrens Medical Group Inc	VA	Pediatrics Physician	$0	$9.1M

David Salib — Billing Profile & Reimbursement Data

Sign up for David Salib — Billing Profile & Reimbursement Data policy alerts

David Salib — Billing Profile & Reimbursement Data

Sign up for David Salib — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References